Andexanet alfa, sold under the brand name Andexxa among others, is an antidote for the medications rivaroxaban and apixaban, when reversal of anticoagulation...
16 KB (1,367 words) - 13:26, 14 October 2024
asfotase alfa (Strensiq), used to treat hypophosphatasia; sebelipase alfa (Kanuma), used to treat lysosomal acid lipase deficiency, and andexanet alfa (Andexxa)...
20 KB (1,378 words) - 23:33, 13 October 2024
DOACs are not as widely studied, idarucizumab (for dabigatran) and andexanet alfa (for factor Xa inhibitor) have been used in clinical settings with varying...
78 KB (8,755 words) - 15:35, 24 September 2024
reuptake inhibitors, and nonsteroidal anti-inflammatory drugs (NSAIDs). Andexanet alfa is a US Food and Drug Administration (FDA) approved antidote for apixaban...
25 KB (2,069 words) - 16:34, 23 September 2024
v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide...
22 KB (2,320 words) - 13:06, 15 August 2024
v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide...
24 KB (1,917 words) - 17:27, 12 October 2024
v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide...
10 KB (724 words) - 06:09, 16 July 2024
trials for andexanet alfa as an antidote for Factor Xa inhibitors with few adverse effects, and started Phase III trials. Andexanet alfa was approved...
29 KB (2,612 words) - 21:15, 28 September 2024
v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide...
31 KB (2,777 words) - 08:32, 19 October 2024
v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide...
53 KB (4,975 words) - 03:43, 30 September 2024